Vulnerability Description
Vulnerability in the Oracle Email Center component of Oracle E-Business Suite (subcomponent: User Interface). Supported versions that are affected are 12.1.1, 12.1.2, 12.1.3, 12.2.3, 12.2.4, 12.2.5 and 12.2.6. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Email Center. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Email Center, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Email Center accessible data as well as unauthorized update, insert or delete access to some of Oracle Email Center accessible data. CVSS v3.0 Base Score 8.2 (Confidentiality and Integrity impacts).
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Oracle | Email Center | 12.1.1 |
References
- http://www.oracle.com/technetwork/security-advisory/cpujan2017-2881727.htmlPatchVendor Advisory
- http://www.securityfocus.com/bid/95593Third Party AdvisoryVDB Entry
- http://www.securitytracker.com/id/1037639
- http://www.oracle.com/technetwork/security-advisory/cpujan2017-2881727.htmlPatchVendor Advisory
- http://www.securityfocus.com/bid/95593Third Party AdvisoryVDB Entry
- http://www.securitytracker.com/id/1037639
FAQ
What is CVE-2017-3275?
CVE-2017-3275 is a vulnerability with a CVSS score of 8.2 (HIGH). Vulnerability in the Oracle Email Center component of Oracle E-Business Suite (subcomponent: User Interface). Supported versions that are affected are 12.1.1, 12.1.2, 12.1.3, 12.2.3, 12.2.4, 12.2.5 an...
How severe is CVE-2017-3275?
CVE-2017-3275 has been rated HIGH with a CVSS base score of 8.2/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2017-3275?
Check the references section above for vendor advisories and patch information. Affected products include: Oracle Email Center.